Most Recent

image: Mass Spec Analysis of Protein Interactions

Mass Spec Analysis of Protein Interactions

By | October 1, 2016

Using the technique to study how RNA, DNA, lipids, and small molecules interact with proteins

0 Comments

image: Free Flow

Free Flow

By | December 1, 2015

A sampling of free software for flow cytometry data analysis

0 Comments

image: Cracking the Complex

Cracking the Complex

By | November 1, 2015

Using mass spec to study protein-protein interactions

0 Comments

image: Messages in the Noise

Messages in the Noise

By | August 1, 2015

After spending more than a decade developing tools to study patterns in gene sequences, bioinformaticians are now working on programs to analyze epigenomics data.

0 Comments

image: Flow Cytometry On-a-Chip

Flow Cytometry On-a-Chip

By | June 1, 2015

Novel microfluidic devices give researchers new ways to count and sort single cells.

0 Comments

image: Getting Your Sugar Fix

Getting Your Sugar Fix

By | April 1, 2015

A guide to glycan microarrays

1 Comment

image: In Custody

In Custody

By | April 1, 2015

Expert tips for isolating and culturing cancer stem cells

1 Comment

image: Sorting Made Simpler

Sorting Made Simpler

By | December 1, 2014

A guide to affordable, compact fluorescence-activated cell sorters

1 Comment

image: Nuclear Cartography

Nuclear Cartography

By | October 1, 2014

Techniques for mapping chromosome conformation

0 Comments

image: Entry Requirements

Entry Requirements

By | September 1, 2014

Recent developments in cell transfection and molecular delivery technologies

0 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham